Repligen (RGEN) Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Operating Expenses data on file, last reported at $178.3 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $178.3 million, up 9.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $698.8 million (up 2.36% YoY), and the FY2025 annual result was $683.1 million, up 2.02% from the prior year.
• Operating Expenses declined to $178.3 million in Q1 2026 per RGEN's latest filing, from $180.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $204.0 million in Q4 2024 and troughed at $136.5 million in Q3 2023.
• A 5-year average of $158.4 million and a median of $153.4 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 37.52% in 2022, then dropped 11.76% in 2025.
• A 5-year view of Operating Expenses shows it stood at $137.9 million in 2022, then rose by 13.65% to $156.7 million in 2023, then surged by 30.18% to $204.0 million in 2024, then dropped by 11.76% to $180.0 million in 2025, then decreased by 0.96% to $178.3 million in 2026.
• Business Quant data shows RGEN's Operating Expenses at $178.3 million in Q1 2026, $180.0 million in Q4 2025, and $172.0 million in Q3 2025.